Positive Outlook for Legence Corp Following Q3 Results
Legence Corp (NASDAQ: LGN) has recently released its third-quarter earnings report, showcasing a mixed performance that has sparked interest among analysts. With a reported revenue of $708.01 million, Legence saw a substantial increase of 26.2% compared to the previous year. This figure surpassed the expectations set by analysts, which were at $639.78 million.
Revenue Growth and Margins
While the revenue growth is commendable, the gross margin did experience a slight decline, dropping to 20.9% from 21.1% a year earlier. Furthermore, earnings fell short of forecasts, with an EPS loss of 2 cents, contrasting with the consensus estimate that projected a profit of 6 cents.
Strategic Acquisition Announcement
In an exciting development, Legence announced its intention to acquire The Bowers Group for approximately $475 million. This acquisition will consist of $325 million in cash, $100 million in stock options, and an additional $50 million in deferred consideration that will be payable either in cash or stock by the end of 2026. This strategic move showcases Legence's commitment to growth and expansion in the market.
Fourth Quarter Projections
Looking ahead to the fourth quarter, Legence anticipates revenue in the range of $600 million to $630 million. This projection aligns closely with market expectations, which stand at an average of $608.45 million. Additionally, the company aims for adjusted EBITDA of between $60 million and $65 million.
Long-Term Revenue Expectations
For fiscal 2026, Legence is projecting revenue to reach between $2.65 billion and $2.85 billion, surpassing the current consensus estimate of $2.63 billion. Concurrently, the adjusted EBITDA is expected to fall between $295 million and $315 million, further illustrating Legence's positive outlook.
Market Response to Earnings Announcement
The market reacted positively to Legence's latest earnings report, with shares climbing by 3.7% to reach $41.77 on the following Monday. This uptick reflects investor confidence in the company's strategic direction and growth potential.
Analyst Revisions on Price Targets
As a result of the recent earnings announcement, several analysts have revised their price targets for Legence's stock:
BMO Capital's Perspective
BMO Capital analyst Devin Dodge has maintained an Outperform rating for Legence while raising the price target from $36 to $46.
RBC Capital's Forecast
RBC Capital's analyst Sabahat Khan also holds an Outperform rating and has increased the price target from $36 to $48.
Goldman Sachs' Projection
Goldman Sachs analyst Adam Bubes kept a Buy rating on Legence and adjusted the price target upwards from $37 to $46.
Barclays' Rating Update
Finally, Barclays analyst Adam Seiden maintained an Equal-Weight rating and elevated the price target from $34 to $37.
Analyst Sentiment on LGN Stock
Given these developments, many investors may be considering buying LGN stock. Below we summarize some analysts' thoughts on the matter:
What Analysts Are Saying
Analysts suggest that potential investors pay attention to the positive trends in revenue and strategic acquisitions, which reflect Legence's commitment to driving long-term growth in its sector.
Frequently Asked Questions
What were Legence's earnings for Q3?
Legence reported a revenue of $708.01 million for Q3, exceeding analyst expectations.
How did the market react to Legence's Q3 results?
Legence's shares increased by 3.7% after the earnings announcement, indicating positive investor sentiment.
What is the projected revenue for fiscal 2026?
Legence projects its revenue to be between $2.65 billion and $2.85 billion for fiscal 2026.
Have any analysts changed their price targets for Legence?
Yes, several analysts have raised their price targets for Legence following the Q3 earnings report.
What is Legence's expected revenue range for Q4?
For Q4, Legence expects revenue between $600 million and $630 million.
